Study on Sacituzumab Govitecan for Treating Recurrent Ovarian, Endometrial, and Cervical Cancers | Clinical Trial

Study on Sacituzumab Govitecan for Treating Recurrent Ovarian, Endometrial, and Cervical Cancers | Clinical Trial | Right2Hope